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Introduction: Accumulating evidence for the co-occurrence autism spectrum disorder
(ASD) and schizotypal personality disorder (SPD) at both the diagnostic and symptom
levels raises important questions about the nature of their association and the effect of
their co-occurrence on the individual’s phenotype and functional outcome. Research
comparing adults with ASD and SPD, as well as the impact of their co-occurrence on
outcomes is extremely limited. We investigated executive functioning in terms of response
inhibition and sustained attention, candidate endophenotypes of both conditions, in adults
with ASD, SPD, comorbid ASD and SPD, and neurotypical adults using both categorical
and dimensional approaches.
Methods: A total of 88 adults (Mean Age = 37.54; SD = 10.17): ASD (n = 26; M/F = 20/6);
SPD (n = 20; M/F = 14/6); comorbid ASD and SPD (n=9; M/F=6/3) and neurotypicals
(n=33; M/F=23/10) completed the Sustained Attention to Response Task (SART) in both
its fixed and random forms. Positive and autistic symptom severity was assessed with the
positive subscale of the Positive and Negative Syndrome Scale (PANSSpos) and the
PANSS Autism Severity Score (PAUSS), respectively.
Results: Controlling for full scale IQ, working memory and medication dosage, group
analyses revealed that the comorbid group committed fewer omission errors than the
ASD group on the fixed SART, and fewer omission errors than the ASD and SPD groups
on the random SART. The individual difference analyses of the entire sample revealed that
the PANSSpos and PAUSS interactively reduced omission errors in both the fixed and
random SARTs, as well as increased d’ scores, indicative of improved overall
performance. We observed no significant results for commission errors or reaction time.
Conclusions: Concurrent elevated levels of autistic and positive psychotic symptoms
seem to be associated with improved sustained attention abilities (reduced omission
errors) but not inhibition (commission errors). Our findings highlight the importance ofg August 2020 | Volume 11 | Article 7981
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Frontiers in Psychiatry | www.frontiersin.orinvestigating the concurrent effect of ASD and SPD at both the symptom and diagnostic
levels, and raise important questions for future research regarding the clinical and
behavioral phenotypes of adults with dual diagnosis and, more generally, about the
nature of the relationship between ASD and SPD.Keywords: attention, comorbidity, executive function, inhibition, schizotypy, The Sustained Attention Response to
Task (SART), vigilanceINTRODUCTION
Autism spectrum disorder (ASD) and schizotypal personality
disorder (SPD) are considered diagnostically independent (1).
ASD is a neurodevelopmental disorder typically associated with
impairments in social development, language, and repetitive,
circumscribed behaviours/interests. SPD is a nonpsychotic
schizophrenia spectrum disorder (SSD) involving milder
symptoms of schizophrenia, and can be diagnosed in children as
young as 6 years of age (2–4). However, the nosologic separation
between them is not clear (5), particularly in light of accumulating
evidence suggesting that ASD and SPD share etiological and risk
factors, and that they can co-occur at both the diagnostic and
symptom/trait levels (6–8). For example, reports show that 41% of
adolescents with ASD met the DSM-IV-TR diagnostic criteria for
SPD (9). Moreover, schizotypal symptoms are found at significant
levels in children with ASD (2), and vice versa (10). This raises
important questions about the nature of their association and the
effect of their co-occurrence on the individual’s phenotype and
functional outcome. It has been recommended that informing
etiological and phenotypic overlaps between ASD and SSD would
require the utilization of a dual-diagnosis cohort compared with
two control groups, each singly diagnosed with ASD or SSD (11),
and that the development of a multidimensional model for
understanding the relationship between these two spectra would
require cohorts to be described not solely by diagnosis, but also by
using dimensional measures that cut across diagnostic boundaries
(11–14). To fill in this gap, the current study investigated executive
functioning in terms of response inhibition and sustained
attention in adults with ASD, SPD, comorbid ASD and SPD
(CM), and neurotypical adults using both categorical and
dimensional approaches.
Dysfunction associated with sustained attention and inhibition
has been proposed as endophenotypes for both conditions (15–17),
and thus they represent common features wherein the relationship
between the two disorders can be evaluated. Since we examine
sustained attention and inhibition with The Sustained Attention to
Response Task (SART) (18), our survey of the literature has
primarily focused on studies that have utilized this task in
particular in both its random and fixed versions (see Materials
and Methods). Research in SSD, both at the diagnostic and
dimensional levels, reports performance difficulties on the SART
(19–21). For example, O’Gráda et al. (19) showed that the
schizophrenic group was more impaired than controls on
sustained attention (measured through omission errors), but not
inhibition (measured throughcommission errors), and that severity
of negative symptoms correlated with difficulties in sustainingg 2attention. Another study (20) found no statistically significant
differences in commission errors between healthy controls,
individuals with schizotypal features, and schizophrenic patients,
nor an association between schizotypal features or schizophrenia
symptomswith anyof the SART’s performance indices.However, it
reported differences in overall task performance, with the
schizotypy group intermediately positioned. With respect to ASD,
one study (22) showed that while the ASD children did not show
sustained attention deficits (measured through omission errors), it
showeddissociation in response inhibition performance (measured
through commission errors), but only on the randomversion of the
SART. Similar results were reported in elderly with ASD while
performing the fixed SART (23); compared to controls, they made
morecommissionerrors anda similarnumberofomissionerrors.A
later study (24) also reported the absence of sustained attention
deficits in ASD children, but not for those with comorbid ADHD.
Research directly comparing ASD and SSD on executive
function in adults is extremely limited. In one study,
Demetriou et al. (25) compared executive function in young
adults with ASD, Early Psychosis, and Social Anxiety Disorder,
using a battery of neuropsychological and self-report
assessments. Relative to the typically developing group, the
ASD group was impaired on mental flexibility, sustained
attention and fluency, while the early psychosis group was
impaired on sustained attention and attentional shifting.
Notably, the early psychosis group was significantly more
impaired than the ASD group on sustained attention. To our
knowledge, only one study (26)—albeit in male children—
compared response inhibition in ASD and SSD using the fixed
version of the SART. They found that both the ASD and SSD
groups had significantly lower correct responses than the
typically developing group, and that the SSD group had slower
reaction time and lower efficiency than the ASD group. With
respect to response inhibition, the commission error rate in the
ASD group was higher than the typical developing group, and
non-significantly different from the SSD group.
Taken together, results from previous SART studies in ASD
and SSD suggest that while ASD appears to be primarily
associated with response inhibition problems, SSD appears to
be associated with sustained attention deficits.
We are only aware of one study, performed in children, that has
directly compared executive functioning in ASD, SPD, and CM
groups (3). Results showed that while the overall performance of the
ASD and SPD groups on the intra-/extra-dimensional set-shifting
(IED) task was worse than the typically developing group, the
overall performance of the CM group was significantly better than
the ASD and SPD groups, and not significantly different from theAugust 2020 | Volume 11 | Article 798
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developing group, clear distinctions between the ASD and SPD
groups were present. Specifically, the ASD group had difficulties
with extra-dimensional shifts, and the SPD group with intra-
dimensional shifts. The study found no differences between the
groups in non-verbal short-term or working memory, or
response inhibition.
Given previous findings from studies using the SART, it was
hypothesized that the frank clinical groups would demonstrate
performance deficits on the SART relative to the neurotypical
group. Specifically, relative to the neurotypical group, we
predicted worse performance on response inhibition for the
ASD group, and worse performance on sustained attention for
the SPD group. In addition, based on evidence for improved
performance in children with comorbid ASD and SPD on the
IED task (3), and the fact that performance on the SART requires
the recruitment of both sustained attention and response
inhibition (22), we hypothesized that the CM group might
perform better than the ASD and SPD groups, and that it
would show no or attenuated impairment relative to the
neurotypical group. This hypothesis is conceivable if we
assume that response inhibition and sustained attention
represent two poles of irregularities across the autism and
schizotypal spectra that converge in a compensatory manner in
the CM group. From a dimensional perspective, a corollary
hypothesis would be to expect performance benefits in
individuals jointly expressing elevated levels of autistic and
positive psychotic symptoms.MATERIALS AND METHODS
Participants
A total of 88 individuals participated in the study (Mean age
(SD) = 37.54(10.17); Male/Female = 63/25). The sample, which
has been previously used in another study (27), consisted of an
ASD, SPD, comorbid (CM), and neurotypical (NT) control
groups (see Table 1 for demographic and clinical details). As
previously described (27), individuals with ASD were recruited
from clinical and support services in Southeast Scotland. All had
a DSM-IV diagnosis of either autism or Asperger Syndrome and
met ASD cut-offs on the Autism Diagnostic Observational
Schedule-Generic (ADOS-G) (28). Individuals with SPD were
recruited from nonpsychotic people who had previously
participated in the Edinburgh High Risk Study of
schizophrenia (EHRS) (29), and from clinical services in
Southeast Scotland. All met DSM-IV criteria for SPD using the
Structured Clinical Interview for DSM-IV Axis II Disorders
(SCID-II) (30). Individuals in the comorbid group met criteria
for both ASD (determined by DSM-IV and the ADOS) and SPD
(determined by the SCID-II). Finally, controls were recruited
from participant and investigator acquaintances and the Scottish
Mental Health Network research register. Individuals with a
history of, or first degree relative with ASD, SPD, or a psychotic
illness were excluded. General exclusion criteria were IQ < 70,
substance dependence or history of schizophreniform disorder,Frontiers in Psychiatry | www.frontiersin.org 3schizophrenia or bipolar affective disorder. Full Scale Intelligence
Quotients (FSIQ) was assessed with the Wechsler Abbreviated
Intelligence Scale (31). The study was approved by the NHS
Lothian Research Ethics Committee. Written informed consent
was obtained from all participants.
Assessments
In addition to the ADOS-G, the SCID-II, and FSIQ, all
participants were assessed with the Positive and Negative
Syndrome Scale (PANSS) (32). From the PANSS, both the
positive and the PANSS autism severity score (PAUSS) subscale
were calculated. The PAUSS (33) is a validated dimensional
measure of autism symptom severity in individuals with
schizophrenia, and consists of PANSS items indicative of
autistic behavior: difficulties in social interaction (Items N1, N3,
N4), difficulties in communication (Items N5, N6), and limited,
repetitive, and stereotypic patterns of behavior (Items N7, G5,
G15). The PAUSS has been shown to be a sensitive measure of
autism symptom severity in young people with first-episode
psychosis (34), and in individuals with schizophrenia (35–38).
The internal consistency of the PAUSS in this study was fair
(Cronbach’sa = 0.75). For the PANSS positive, Cronbach’sawas
0.62. However, the average inter-item correlation was good
(rIICorAvg = 0.164), which is a more suitable measure of internal
consistency for scales less than 10 items (39).
For those on antipsychotic medication, doses were converted
to chlorpromazine (CPZ) equivalents (40, 41).
Working Memory
FollowingO’Gráda et al. (19), we included workingmemory to index
higher ‘executive’ functioning, which was assessed using the letter-
number sequencing (LNS) task from theWechsler Adult Intelligence
Scale, 3rd edition [WAIS-III, (42)]. In this task, individuals were
presented with a pseudorandom series of numbers and letters. They
were then asked to respond with the numbers first in numerical
order, followed by the letters in alphabetical order. The task consisted
of 7 levels with gradually increasing number of components (ranging
from level 1 with two components – one letter and one number, to
level 7 with 8 components). Each level contained 3 items. For the
current study, performance on the LNS was considered for the level
reached and the total number of correctly recalled sequences
(Maximum score = 21).
The Sustained Attention Response to
Task (SART)
The SART (18) was employed in both its fixed and random
forms (22). Figure 1 provides a summary of the random version
of the task. In both forms, numbers between 1 and 9 were
presented on a laptop screen 225 times over 4 min and 19 s. The
numbers were in one of 5 different font sizes and no font size
occurred more than twice in a row. Each number appeared on
the screen for 250 ms and was followed by a mask (a cross in a
circle) for 900 ms. Participants were asked to press the space bar
for every number (Go trials) except for the number 3 (No-go
trials). In order to minimize impulsive responses, they were
asked to not press the space bar until the appearance of the mask.August 2020 | Volume 11 | Article 798
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repeated cycles of a fixed ascending order (i.e., 1, 2, 3, 5, 6, 7, 8, 9,
1, 2,…). In the random form, the numbers are presented in a
pseudorandom order. In both versions, each number appears 25
times. All participants completed the Fixed SART followed by
the Random SART.
The SART differs from traditional continuous performance
tasks in that it requires the inhibition of response to an
infrequent target as opposed to requiring a response to an
infrequent target. Withholding of the primed response is
suggested to place greater load on sustained attention networks
(18). Clearly, in addition to sustained attention, individuals must
also show intact response inhibition to perform the SART. To the
extent that response inhibition and sustained attention can be
dissociable, the use of the fixed and random forms of the SART
allows these two aspects of performance to be dissociated. The
Random SART places greater load on inhibitory functions than
the Fixed SART due to the random presentation of either Go orFrontiers in Psychiatry | www.frontiersin.org 4No-go trials, whereas the Fixed SART places relatively greater
demand on attentional compared to inhibitory functions due to
the predictable nature of the Go and No-go trials (22).
Performance on the SART is measured through the number
of omission (failed Go trials) and commission (failed No-go
trials) errors. Omission errors on both versions of the SART are
related to lapses in sustained attention. Commission errors on
the random SART are related to difficulties in both sustained
attention and response inhibition, whereas commission errors on
the Fixed SART are primarily related to lapses in sustained
attention with a much smaller load being placed upon response
inhibition. In addition, overall performance, d-prime (d’), was
calculated as the standardized difference between hits and false
alarms as follows: d’ = z(H) - z(F). A correction was applied when
the rate of false alarms was zero [1/(2Nlures)], and when the rate
of hits was one [1-1/(2Ntargets)].
We also recorded response reaction time (RT) of correct
responses for both tasks.TABLE 1 | Demographics and clinical characteristics of the study groups.
Variables* NT (N = 33) ASD (N = 26) SPD (N = 20) CM (N = 9) Stat F/c2/H p-value
Gender (M:F) 23:10 20:6 14:6 6:3 0.72b 0.88
Age 36.53
(9.33)
39.65
(11.89)
37.26
(9.42)
35.80
(10.03)
0.56a 0.64
FSIQ 118.06
(9.86)
114.81
(16.75)
106.40
(10.69)
102.44
(23.61)
4.68a 0.005
SPD, CM < NTd
LNS Level 5.64
(1.19)
4.62
(1.13)
5.00
(1.38)
3.89
(1.54)
14.35c 0.002
ASD, CM < NTd
LNS Total 13.39
(2.65)
11.54
(3.09)
11.60
(3.47)
10.7
(4.30)
7.67c 0.053
PANSS positive 7.52
(1.16)
9.92
(2.67)
12.95
(2.37)
14.11
(2.42)
48.05c <0.001
SPD, CM > ASD > NTd
PAUSS 8.00
(0.00)
12.88
(4.29)
11.63
(3.18)
14.89
(5.21)
33.12c <0.001
ASD, SPD, CM > NTd
PAUSS Social 3.00
(0.00)
4.66
(2.21)
4.47
(2.09)
5.44
(2.24)
19.11c <0.001
ASD, SPD, CM > NTd
PAUSS Communication 2.00
(0.00)
3.46
(1.77)
3.00
(1.25)
4.67
(2.29)
22.90c <0.001
ASD, SPD, CM > NTd
PAUSS Stereotypies 3.00
(0.00)
4.77
(1.53)
4.16
(1.50)
4.78
(1.64)
18.48c <0.001
ASD, CM > NTd
CPZ 0.00
(0.00)
3.85
(13.56)
23.75
(52.24)
63.89
(135.27)
12.73c 0.005
SPD, CM > NTdAugust 2020 |*Continuous variables are presented in means with standard deviations.
M, Male; F, Female; FSIQ, Full Scale Intelligence Quotients; LNS, Letter Number Sequencing; PANSS positive, Positive Subscale of the Positive and Negative Syndrome Scale; PAUSS,
PANSS Autism Severity Scale; CPZ, Chlorpromazine equivalents;
aF statistics; bFisher’s exact test; cKruskal-Wallis Test (H); dBonferroni corrected.
The p-values are indicated under the p-value column (right most column), and significant values are in bold.FIGURE 1 | Schematic diagram of the Random Sustained Attention to Response Task.Volume 11 | Article 798
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Differences in demographics and clinical variables of the groups
were analyzed using F, c2, and H statistics, as appropriate. Group
analyses of the omission and commission errors of the fixed and
random SART tasks were performed using Generalized Linear
Models (GLMs) with negative binomial distribution, using Wald
chi-square statistics. A negative binomial distribution is
appropriate for the analysis of count data and when the
expected variance is greater than the mean (43, 44). The shape
parameter k of the negative binomial distribution of each of the
omission/commission errors was calculated as follows: k = m
2
v−m ,
where m is the mean and v is the variance (43). d’ scores,
indicative of overall performance on the SART tasks, were
analyzed with GLMs, using the identity link function. Mean
reaction time to correct responses was analyzed with GLMs,
using the log link function. All group analyses were conducted
while controlling for FSIQ, LNS level, and CPZ on which the
groups differed (see Table 1).
Individual difference analyses of SART outcome measures
were also analyzed as a function of PANSSpos, PAUSS and their
interaction using GLMs as above, while controlling for FSIQ,
LNS level, CPZ, and diagnosis. Analyses were performed using
SPSS Version 24. Significant interactions were probed with the
Johnson-Neyman method in R Studio (45). The Johnson-
Neyman method provides a “high-resolution picture” of the
interaction by estimating the value(s) of one predictor at which
the other predictor has a significant effect on the outcome
measure. This is established by identifying the precise value(s)
along the continuum of one predictor for which the regression
slopes of the other predictor are estimated to be significantly
different from zero.
Unless it is otherwise noted, all p-values are FDR adjusted (q-
value = 0.05) for multiple testing (46). Effect sizes are reported in
terms of Pseudo-R2 and Cohen’s d.Frontiers in Psychiatry | www.frontiersin.org 5RESULTS
Preliminary analyses are presented in Tables 1 and 2. Table 1
presents the demographics and clinical characteristics of the
study groups. Group comparisons did not reveal differences in
age, gender distribution, or the total number of correctly
recalled sequences of the LNS task. However, significant
group differences were observed in FSIQ, LNS level, and
CPZ dosage.
Table 2 presents the correlations between the study variables.
We note that neither the PAUSS nor the PANSS positive
significantly correlated with either the Fixed or Random SART
outcome measures.
Group Differences in Fixed and
Random SART
Figure 2 depicts the results of the group analyses on omission
and commission errors and overall performance (d’) of the fixed
and random SART tasks. Figure 3 depicts the results of the
group analyses on mean reaction time of correct responses of the
fixed and random SART tasks.
Fixed SART Omission Errors
The overall model was significant (c2 = 63.71, df = 6, pcorr <
0.001, Pseudo R2 = 0.12). As can be seen in Figure 2A, there
was a significant main effect for group (Waldc2 = 13.94, df =
3; p = 0.003) such that the CM group made fewer errors than
the ASD group (MD(se) = -2.59(0.77), pcorr = 0.005, Cohen’s
d = 0.79). The ASD group made more errors than the NT
group at a trend level (MD(se) = 2.20(0.89); pcorr = 0.065,
Cohen’s d = 0.68). This was independent of the significant
effect of FSIQ, where increasing FSIQ scores were associated
with fewer errors (b(se) = - 0.009(0.002), Waldc2 = 33.64,
df = 1; pcorr < 0.001).TABLE 2 | Spearman’s correlations between the study variables in the entire sample*.
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
1. Age 0.02 -0.02 -0.07 -0.04 0.18 0.22 -0.09 0.00 -0.02 -0.08 0.05 0.08 0.02 0.03
2. FSIQ 0.02 0.42 0.47 -0.18 -0.25 -0.29 -0.42 -0.36 -0.28 -0.29 0.39 0.34 -0.10 -0.01
3. LNS Level -0.01 0.42 0.89 -0.30 -0.18 -0.35 -0.32 -0.38 -0.29 -0.23 0.37 0.29 -0.19 -0.06
4. LNS Total -0.07 0.47 0.89 -0.18 -0.11 -0.24 -0.35 -0.42 -0.28 -0.30 0.42 0.33 -0.13 0.03
5. CPZeq -0.04 -0.18 -0.30 -0.18 0.41 0.24 0.08 0.13 0.05 -0.07 -0.11 0.02 0.25 0.20
6. PANSS Pos. 0.18 -0.25 -0.18 -0.11 0.41 0.51 0.15 0.09 0.01 0.08 -0.14 -0.08 0.05 0.05
7. PAUSS 0.22 -0.29 -0.35 -0.24 0.24 0.51 0.17 0.08 0.02 0.05 -0.14 -0.07 0.13 0.08
8. F SART OE -0.09 -0.42 -0.32 -0.35 0.08 0.15 0.17 0.66 0.56 0.60 -0.89 -0.68 -0.21 -0.26
9. F SART CE 0.00 -0.36 -0.38 -0.42 0.13 0.09 0.08 0.66 0.47 0.58 -0.91 -0.62 -0.11 -0.26
10. R SART OE -0.02 -0.28 -0.29 -0.28 0.05 0.01 0.03 0.56 0.47 0.47 -0.56 -0.68 -0.04 -0.06
11. R SART CE -0.08 -0.29 -0.23 -0.30 -0.07 0.08 0.05 0.60 0.58 0.47 -0.66 -0.95 -0.50 -0.71
12. F SART d’ 0.05 0.39 0.37 0.42 -0.11 -0.14 -0.14 -0.89 -0.91 -0.56 -0.66 0.72 0.19 0.31
13. R SART d’ 0.08 0.34 0.29 0.33 0.02 -0.08 -0.07 -0.68 -0.62 -0.68 -0.95 0.72 0.42 0.58
14. F CR RT 0.02 -0.10 -0.19 -0.13 0.25 0.04 0.13 -0.21 -0.11 -0.04 -0.50 0.19 0.42 0.66
15. R CR RT 0.03 -0.01 -0.06 0.03 0.20 0.05 0.08 -0.26 -0.26 -0.06 -0.71 0.31 0.58 0.66August 2020 | Volume 11 | ArticFSIQ, Full Scale Intelligence Quotients; LNS, Letter Number Sequencing; PANSS pos, Positive Subscale of the Positive and Negative Syndrome Scale; PAUSS, PANSS Autism Severity
Scale; CPZ, Chlorpromazine equivalents; F SART, Fixed SART; R SART, Random SART; OE, Omission errors; CE, Commission errors; d’, d prime; F CR RT, Fixed SART Correct
Responses Mean Reaction Time; R CR RT, Random SART Correct Responses Mean Reaction Time;
* Coefficients in bold are significant (p < 0.05). Coefficients above the diagonal are FDR adjusted for multiple tests.le 798
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The overall model was non-significant (c2 = 7.61, df = 6, pcorr =
0.357). See Figure 2B.
Fixed SART d Prime
The overall model was significant (c2 = 18.58, df = 6, pcorr = 0.013,
Pseudo R2 = 0.19). Better task performance was significantly
associated with FSIQ (b(se) = 0.018(0.008), Waldc2 = 5.45, df =
1; p = 0.020), and higher LNS levels (b(se) = 0.181(0.087),Waldc2 =
4.30, df = 1; p = 0.038). However, as can be seen from Figure 2C,
the difference between the groups was non-significant (Waldc2 =
1.64, df = 3; p = 0.644).
Fixed SART Mean Reaction Time of Correct
Responses
The overall model was non-significant (c2 = 9.10, df = 6,
pcorr = 0.269). See Figure 3A.Frontiers in Psychiatry | www.frontiersin.org 6Random SART Omission Errors
The overall model was significant (c2 = 143.55, df = 6, pcorr <
0.001, Pseudo R2 = 0.37). There was a significant main effect of
group (Waldc2 = 31.72, df = 3; p < 0.001) such that the CM
group made fewer errors than the ASD (MD(se) = -0.88(0.18);
pcorr < 0.001, Cohen’s d = 0.80) and SPD (MD(se) = -0.64 (0.21);
pcorr = 0.012, Cohen’s d = 0.74) groups (see Figure 2D). This was
independent of the significant effects of FSIQ, LNS levels and
CPZ dosage, where increasing FSIQ (b(se) = - 0.031(0.004),
Waldc2 = 66.80, df = 1; p < 0.001), and LNS level (b(se) = - 0.173
(0.057), Waldc2 = 9.11, df = 1; p = 0.003) were associated with
fewer errors, while higher CPZ dosage was associated with more
errors (b(se) = 0.003(0.001), Waldc2 = 5.37, df = 1; p = 0.021).
Random SART Commission Errors
The overall model was non-significant (c2 = 4.91, df = 6, pcorr =
0.635). See Figure 2E.A B
D E F
C
FIGURE 2 | Groups comparisons on omission errors, commission errors and overall performance (d’) in the fixed (A–C) and random (D–F) SART tasks. NT,
Neurotypical Controls; ASD, Autism Spectrum Disorder; SPD, Schizotypal Personality Disorder; CM, Comorbid group. Error bars represent standard error of the
mean (SEM). *p < 0.05, **p < 0.01, ***p < 0.001.A B
FIGURE 3 | Groups comparisons on mean response time (in milliseconds) of appropriate responses in the fixed (A) and random (B) SART tasks. NT, Neurotypical
Controls; ASD, Autism Spectrum Disorder; SPD, Schizotypal Personality Disorder; CM, Comorbid group. Error bars represent standard error of the mean (SEM).August 2020 | Volume 11 | Article 798
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The overall model was significant (c2 = 15.24, df = 6, pcorr =
0.037, Pseudo R2 = 0.16). Task performance was marginally
associated with FSIQ (b(se) = 0.015(0.008), Waldc2 = 3.48, df =
1; p = 0.062) and LNS level (b(se) = 0.161(0.093), Waldc2 = 3.02,
df = 1; p = 0.082). The difference between the groups was non-
significant (Waldc2 = 1.52, df = 3; p = 0.678). See Figure 2F.
Random SART Mean Reaction Time of Correct
Responses
The overall model was non-significant (c2 = 1.83, df = 6, pcorr =
0.935). See Figure 3B.
Individual Difference Analyses: Fixed SART
Fixed SART Omission Errors
The overall model was significant (c2 = 65.85, df = 9, pcorr <
0.001, Pseudo R2 = 0.33). Parameter estimates revealed a
significant negative PAUSS x PANSSp interaction on omission
errors (b(se) = - 0.067(0.027), Waldc2 = 6.21, df = 1; p = 0.013).
Fixed SART Commission Errors
The overall model was non-significant (c2 = 8.64, df = 9, pcorr= 0.539).
Fixed SART d Prime
The overall model was significant (c2 = 24.23, df = 9, pcorr =
0.011, Pseudo R2 = 0.30). Parameter estimates revealed aFrontiers in Psychiatry | www.frontiersin.org 7significant positive PAUSS x PANSSp interaction on d’ prime
(b(se) = 0.302(0.101), Waldc2 = 8.94, df = 1; p = 0.003).
The results of the interaction probes for the omission
errors and overall performance (d’) of the fixed SART task
are summarized in Figure 4. Figures 4A, B depict the results
for the omission errors. Figure 4A shows that the PAUSS is
associated with a significant increase in omission errors when
PANSS positive is ≤ - 0.76 SD from the mean, but with a
significant decrease in errors when PANSS positive is ≥ 0.69
SD from the mean. Conversely, Figure 4B shows that PANSS
positive is significantly associated with an increase in errors
when PAUSS is ≤ 1.08 SD from the mean, but with a
significant decrease in errors when PAUSS is ≥ 3.23 SD
from the mean.
Figures 4C, D depict the results for d’. Figure 4C shows that
PAUSS is significantly associated with better performance when
PANSS positive is ≥ 1.47 SD from the mean. Conversely, Figure
4D shows that PANSS positive is significantly associated with
worse performance when PAUSS is ≤ - 0.04 SD from the mean,
but with significantly better performance when PAUSS is ≥ 3.46
SD from the mean, albeit this is outside the range of the PAUSS
scores in our data [PAUSS range = -0.89, 3.40].
Fixed SART Reaction Time
The overall model was non-significant (c2 = 11.71, df = 9,
pcorr = 0.368).A B
DC
FIGURE 4 | Results of the Johnson-Neyman interaction probes for omission errors (OE) and d prime scores (d’) of the Fixed Sustained Attention to Response Task
(SART) task. (A, C) depict the association (b weights) of the Positive and Negative Syndrome Scale (PANSS) Autism Severity (PAUSS) scores with OE and d’,
respectively, along the range of the standardized values of the PANSS positive scores. (B, D) depict the association (b weights) of the PANSS positive scores with
OE and d’, respectively, along the range of the standardized values of the PAUSS scores. Areas shaded in dark grey represent the zone of significant effects (p <
0.05), and areas shaded in light gray represent the zone of non-significant effects (p > 0.05). Slopes are bounded by 95% confidence intervals.August 2020 | Volume 11 | Article 798
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Random SART
Random SART Omission Errors
The overall model was significant (c2 = 37.80, df = 9, pcorr <
0.001, Pseudo R2 = 0.41). Parameter estimates revealed a
significant and negative PAUSS x PANSS positive interaction
on omission errors (b(se) = - 0.24(0.102), Waldc2 = 5.60, df = 1;
p = 0.018).
Random SART Commission Errors
The overall model was non-significant (c2 = 7.44, df = 9,
pcorr = 0.591).
Random SART D’ Prime
The overall model was significant (c2 = 23.35, df = 9, pcorr =
0.011, Pseudo R2 = 0.291). Parameter estimates revealed a
significant and positive PAUSS x PANSS interaction on errors
(b(se) = 0.253(0.110), Waldc2 = 5.24, df = 1; p = 0.022).
The results of the interaction probes for the omission errors
and overall performance (d’) of the random SART task are
summarized in Figure 5. Figures 5A, B depict the results for
the omission errors. Figure 5A shows that PAUSS is associated
with an increase in omission errors when PANSS positive is ≤ -
0.74 SD from the mean, but with a significant decrease in errors
when PANSS positive is ≥ 0.58 SD from the mean. Conversely,
Figure 5B shows that PANSS positive is associated with an
increase in omission errors when PAUSS is ≤ 0.11 SD from the
mean, but with a significant decrease in errors when PAUSS is ≥Frontiers in Psychiatry | www.frontiersin.org 81.67 SD from the mean. Figures 5C, D depict the results for d’.
Figure 4C shows that PAUSS is significantly associated with
better overall performance when PANSS positive is ≥ 0.44 SD
from the mean. Conversely, Figure 4D shows that PANSS
positive is significantly associated with better overall
performance when PAUSS is ≥ 2.30 SD from the mean.
Random SART Reaction Time
The overall model was non-significant (c2 = 10.69, df = 9,
pcorr = 0.397).
Exploratory Analyses
To gain further insight into the association of the interaction of
PANSS positive x PAUSS scores with reduced omission errors, we
performed a serious of exploratory analyses in the entire sample as
well as in each of the ASD and SPD groups, separately. First, for the
entire sample, we examined the association of PANSS positive with
each of the three subdomains of the PAUSS (i.e., social difficulties,
communication difficulties, and stereotypies/narrowed interests)
with omission errors in both the fixed and random SART tasks to
see if the interactions we observed in the main analyses were driven
by a specific subdomain of autistic features. For each model, we
examined the association of PANSS positive and its interaction with
each of the PAUSS subdomains while controlling for the other two
subdomains as well as for FSIQ, LNS level, CPZ, and diagnosis. In
the fixed SART, omission errors were associated with a negative
PANSS positive x PAUSS stereotypic behavior interaction (b(se) =
-0.112(0.037), Waldc2 = 9.11, df = 1; p = 0.003). The interactions ofA B
DC
FIGURE 5 | Results of the Johnson-Neyman interaction probes for omission errors (OE) and d prime scores (d’) of the Random Sustained Attention to Response
Task (SART) task. (A, C) depict the association (b weights) of the Positive and Negative Syndrome Scale (PANSS) Autism Severity (PAUSS) scores with OE and d’,
respectively, along the range of the standardized values of the PANSS positive scores. (B, D) depict the association (b weights) of the PANSS positive scores with
OE and d’, respectively, along the range of the standardized values of the PAUSS scores. Areas shaded in dark grey represent the zone of significant effects (p <
0.05), and areas shaded in light grey represent the zone of non-significant effects (p > 0.05). Slopes are bounded by 95% confidence intervals.August 2020 | Volume 11 | Article 798
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communication (p = 0.955) subdomains were non-significant. For
the Random SART, omission errors were associated with a negative
PANSS positive x PAUSS stereotypic behavior interaction (b(se) =
-0.547(0.133), Waldc2 = 16.94, df = 1; p < 0.001), as well as with a
negative PANSS positive x PAUSS communication interaction
(b(se) = -0.323(0.129), Waldc2 = 6.24, df = 1; p = 0.013). The
interaction of PANSS positive with the PAUSS social subdomain
was non-significant (p = 0.076).
Following the same analyses we performed for the entire
sample, we explored the association of the PANSS positive x
PAUSS interaction with omission errors in the ASD only group,
and in the SPD only group. The results revealed significant
models only for the random SART in both the ASD (c2 = 17.10,
df = 6, pcorr = 0.018, Pseudo R
2 = 0.52) and SPD (c2 = 21.49, df =
6, pcorr = 0.004, Pseudo R
2 = 0.70) groups. In the ASD group, the
PANSS positive x PAUSS interaction was associated with
reduced omission errors (b(se) = -0.736(0.318), Waldc2 = 5.37,
df = 1; p = 0.021). In the SPD group, while the interaction was
not significant (p = 0.281), the main effects of the PANSS positive
and PAUSS were significant, such that increasing PANSS
positive scores were associated with increased omission errors
(b(se) = 2.595(0.731), Waldc2 = 12.60, df = 1; p < 0.001), and
increasing PAUSS scores were associated with reduced omission
errors (b(se) = -2.736(0.976), Waldc2 = 8.63, df = 1; p = 0.003).
As can be seen from Figures 6A, B, the pattern of associations of
PAUSS and PANSS positive with omission errors in the ASD
group was reversed in the SPD group.DISCUSSION
Using the SART task, we examined executive functioning in
terms of response inhibition and sustained attention, two
candidate endophenotypes in both ASD and SPD. Overall, we
found that while the clinical groups did not differ from healthyFrontiers in Psychiatry | www.frontiersin.org 9controls, there were clear differences between the single diagnosis
groups and the CM group in sustained attention (as measured
with omission errors) but not response inhibition (as measured
with commission errors). The group analyses revealed that the
CM group committed fewer omission errors than the ASD group
in both the fixed and random SART, as well as fewer errors than
the SPD group in the random SART. The individual difference
analyses confirmed and extended these results to show that
autism and positive symptom severity interactively reduced
omission errors. In addition, the individual difference analyses
also revealed that the interaction was associated with better
overall performance (as indexed by higher d’ values). The
individual difference analyses suggest that dimensional
measures are more sensitive than group level analyses, and that
performance might be more aptly characterized by examining
the relative severity of autistic and positive symptoms in the
individual rather than the absence or presence of an ASD or SPD.
Our predictions of increased omission errors in the SPD
group, and increased commission errors in the ASD group
relative to the neurotypical group were not supported by our
findings in either the fixed or random version of the SART. We
also found no statistically significant differences between the four
groups on commission errors, nor between the ASD, SPD, and
NT groups on omission errors. While the lack of differences may
be due to the SART being relatively an easy task to perform, these
results partially overlap with findings from previous research,
although caution is warranted since we are comparing our results
to findings from populations with different diagnoses
(schizophrenia) and at different developmental stages
(children, elderly). With respect to commission errors on the
fixed SART, O’Gráda et al. (19), Chan et al. (20), and Ho et al.
(21) found no differences between healthy controls and
schizophrenic patients, Shi et al. (26) found no differences
between ASD and SSD children, and Johnson et al. (22) found
no differences between ASD and typically developing children. In
contrast, however, Johnson et al. (22) reported higher number ofA B
FIGURE 6 | The association of the PANSS Autism Severity (PAUSS) and PANSS Positive (PANSSpos) scores with omission errors on the Random SART task in the
ASD and SPD groups. (A) shows the association of the standardized PAUSS and PANSSpos scores with the standardized predicted values of the omission errors in
the ASD group, where PAUSS scores are associated with increased omission errors and the PANSSpos scores are associated with reduced omission errors. Here,
the interaction of PAUSS x PANSSpos is significant ASD (b(se) = -0.736(0.318), Waldc2 = 5.37, df = 1; p = 0.021). (B) shows the association of the standardized
PAUSS and PANSSpos scores with the standardized predicted values of the omission errors in the SPD group, where PANSSpos scores are associated with
increased omission errors (b(se) = 2.595(0.731), Waldc2 = 12.60, df = 1; p < 0.001) and the PAUSS scores are associated with reduced omission errors (b(se) =
-2.736(0.976), Waldc2 = 8.63, df = 1; p = 0.003). Here, the PAUSS x PANSSpos interaction is not significant (p = 0.281).August 2020 | Volume 11 | Article 798
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performing the random SART, and Geurts et al. (23) reported
similar results in elderly with ASD while performing the fixed
SART. Moreover, unlike our results, O’Gráda et al. (19) found
that the schizophrenic group made more omission errors than
the controls while performing the fixed SART.
However, we observed differences between the clinical groups
on sustained attention, with the CM group out-performing the
ASD group in the fixed SART and both the ASD and SPD groups
in the random SART. Cognizant of the different tasks and
methodologies employed in other studies, these results are
consistent with the few available studies that compared
individuals with comorbid ASD-SSD to individuals with ASD
or SSD. In children, the performance of those with a dual
diagnosis of ASD and SPD were similar to typically developing
children, and largely better than the children with the frank
conditions on both attentional set shifting and socio-pragmatic
skills (3). In adults, brain activations in the ASD-SPD comorbid
group during a social judgment task were generally
indistinguishable from the typically developing group and fell
intermediately between the ASD and SPD groups (27). More
recently, Sunwoo et al. (47) reported that young people with
comorbid first episode psychosis (FEP) and ASD were: (1) less
likely than young people with FEP only to have comorbid
substance use issues, (2) more likely to be engaged in
employment or education at the time of discharge, but also (3)
more likely to experience impairments in interpersonal skills.
From a dimensional perspective, the results regarding the
association of the interaction of PANSS autistic and positive
symptoms with performance benefits on the SART resonate with
those obtained for social cognition and functioning in patients
with schizophrenia (38) and bipolar I disorder (48). This
tentatively suggests that benefits can be observed in both the
social and attentional domains in comorbid individuals at both
the diagnostic and symptom level. We note, however, no such
benefit was observed for social cognition and functioning in a
sample of individuals with various psychotic disorders that self-
reported autistic traits and positive psychotic experiences (49).
Moreover, O’Gráda et al. (19) found that severity of negative
symptoms correlated with difficulties in sustaining attention.
Intriguingly, this effect was reported for patients in whom the
positive symptoms were low (Mean= 2.02; SD= 2.25). This
appears to parallel our finding where the PAUSS scores were
associated with more omission errors when positive symptoms
were low (see Figures 4A and 5A).
What might explain the benefit we observed in the CM
group and in individual with elevated autistic and positive
symptoms? As stated above, performance on the SART
requires the recruitment of both sustained attention and
response inhibition. However, the hypothesized dissociation
between SPD and ASD in terms of these respective abilities
was not supported by our results, and as such our pattern of
results do not support the hypothesis that these two abilities
converge in a compensatory manner in the CM group. Perhaps
this is inherent in the inability of the SART task to truly
dissociate inhibition from sustained attention. In this regard,Frontiers in Psychiatry | www.frontiersin.org 10Robertson et al. (18) point out that “arbitrating between the
relative contributions of an inefficiency in response inhibition per
se and a failure to inhibit responses due to a lack of continuous
attention to response is of course difficult and indeed somewhat
circular within this task” (p. 749).
However, the exploratory analyses provide some important
leads that might be leveraged in future research to understand
the mechanisms underlying benefits conferred by the co-
presence of autistic and positive symptoms. First, the analyses
pertaining to the subdomains of the PAUSS suggest that autistic
features associated with stereotypies and narrowed interests
appear to largely drive the interaction of the PAUSS total
scores with PANSS positive symptoms on omission errors.
This dovetails with the findings of a study on probabilistic
reasoning showing that relative to individuals with delusional
disorder (DD) only and individuals with obsessive-compulsive
disorder (OCD) only—who respectively were reliant on less and
more evidence to make their decision—probabilistic reasoning
was normalized in individuals with comorbid DD and OCD (50).
Stereotypic behavior is a main feature that is common to both
OCD and ASD (51), and so it might be of particular importance
to understanding how autistic and positive symptoms become
adaptive when co-present.
Moreover, the independent analyses in the ASD and SPD groups
show that the pattern of associations of PAUSS and PANSS positive
symptoms with omission errors in the ASD group is reversed in the
SPD (see Figures 6A, B). This suggests that the PAUSS and PANSS
positive symptoms are associated with diametric influences on
sustained attention independent of the disorder. This is consistent
with (i) the diametric model (52, 53)—which posits that ASD and
SSD are characterized by opposing phenotypic patterns—, (ii)
evidence suggesting that ASD and SSD can be characterized by
opposing patterns of attentional abilities (3, 54), and (iii) existing
evidence suggesting that the presence of both disorders may be
associated with attenuated impairments (3, 27, 38). Importantly, this
pattern of association also suggests that the omission errors in ASD
and SPD might be precipitated by different mechanisms, which is
consistent with the notion that apparent overlaps between autism
and schizophrenia spectrum disorders might be precipitated by
different cognitive styles or biases (55, 56). Altogether, this pattern of
association gives credence to the idea and that some compensatory
mechanism might nonetheless be at play in the comorbid group. If
so, future research (behavioral, cognitive, and neural) is necessary in
order to test the prediction that these mechanisms are highly
interactive and possibly of contrasting nature. Hence, assessments
that require the recruitment of dissociable contrasting abilities, such
as global-local processing (57, 58) and zoom-in and zoom-out
attentional mechanism (59) might be particularly beneficial in
discriminating between the groups and thus potentially
mechanistically more informative. Within the neural domain,
future research might consider the default mode and task-positive
networks in search for a potential mechanism. Lapses in attention
have been associated with reduced task-induced deactivation of the
default mode network (60) and its anticorrelation with the task-
positive network has been related to consistent behavioral
performance (61). Examining disorder-specific resting stateAugust 2020 | Volume 11 | Article 798
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mechanistic account of how autism and positive symptom
severity converge adaptively in sustaining attention.
We acknowledge a number of limitations of our study. First,
findings of our study may be limited by the small sample size of the
CM group. Thus, future work with a larger sample of CM
individuals is needed in order to have a better understanding of
their clinical phenotypes. Second, controls were mainly recruited
through acquaintances. This recruitment strategy may have biased
our sample. Third, as pointed above, the SART offered limited
insight into the mechanisms that might explain the performance
benefits we observed in the comorbid group. Therefore, it would be
profitable for future research to implement a Research Domain
Criteria (RDoC) strategy (62) for a more comprehensive assessment
of the participants’ clinical and functional phenotypes that may help
interpret the current results.
Fourth, while the PAUSS allows for a dimensional cross-disorder
analysis (33), it has been validated against the ADOS that measures
current autistic traits. As such, it may be argued, and particularly for
the SPD group, that the PAUSS merely reflects the severity of later-
onset, autistic-like symptoms rather than actual childhood-onset
autistic traits. While, to our knowledge, the PAUSS is yet to be
validated against instruments that assess childhood-onset autistic
traits, nascent results suggest that PAUSS levels in schizophrenia
patients with ASD, assessed with the Autism Diagnostic Interview-
Revised [ADI-R, (63)]—a measure that is based on the patients’
early developmental history through a parent/caregiver interview—
are similar to those of schizophrenia patients with ASD, assessed
with the ADOS (35). In addition, negative symptoms in
schizophrenia spectrum disorders (from which the PAUSS is
largely derived) have been suggested to be of neurodevelopmental
origin and predate the onset of the disorder (64, 65). Taken together,
the PAUSS may be capturing childhood-onset autistic traits rather
than current autistic-like features. Yet, the current lack of a unified
classification instrument for cross-disorder analysis represents a
general challenge to this young field, and so the development and
refinement of such instruments is crucial to advance research into
underlying cross-disorder mechanisms.Frontiers in Psychiatry | www.frontiersin.org 11In conclusion, comorbid ASD-SPD or concurrent elevated levels
of autistic and positive psychotic symptoms counterintuitively
appear to confer greater functional advantages than simply having
an ASD or SPD alone. These findings raise intriguing questions
about possible mechanisms underlying the observed performance
benefits. While we found no direct support for the hypothesis that
sustaining attention and response inhibition converge in a
compensatory manner in the comorbid group, our findings
suggest that autistic and positive symptoms exert diametric
influences on sustained attention abilities. More broadly, our
findings highlight the importance of investigating the concurrent
effect of ASD and SPD at both the symptom and diagnostic levels,
and it raises important questions and directions for future research
regarding the clinical and behavioral phenotypes of adults with
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